+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

From
Ankylosing Spondylitis Market Report 2025 - Product Thumbnail Image

Ankylosing Spondylitis Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
From
Atopic Dermatitis Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Atopic Dermatitis Drugs Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 190 Pages
  • Global
From
From
Myopia & Presbyopia Treatment Market - Global Forecast 2025-2032 - Product Thumbnail Image

Myopia & Presbyopia Treatment Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 198 Pages
  • Global
From
From
From
From
Cancer biologics Market Report 2025 - Product Thumbnail Image

Cancer biologics Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Loading Indicator